Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.
Sadler
E
E
Schafleitner
B
B
Lanschuetzer
C
C
Laimer
M
M
Pohla-Gubo
G
G
Hametner
R
R
Hintner
H
H
Bauer
J W
JW
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003879:Dermatologic Agents / Q000627:therapeutic use*; D016107:Epidermolysis Bullosa Acquisita / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069283:Rituximab; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D000069283:Rituximab